GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Insecticides (India) Ltd

Insecticides (India) Files Q2 FY27 Earnings Presentation

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 05 Nov 2026, 04:13 PM IST  ·  BSE ID: cb69b789-64ab-47bc-9306-ec99576c13b9
View Original BSE Filing (PDF)
💡
In Simple Terms
Insecticides (India) shared a presentation on its business performance for the quarter and half-year ended September 30, 2026.
🤖 AI Summary
  • Insecticides (India) Limited filed its Earning Presentation for Q2 & H1 of FY27, ended September 30, 2026.
  • The company has a product portfolio of 130+ formulations, 20+ technical products, and 27 patents.
  • Operations include 6 formulation plants, 2 technical plants, and 4 state-of-the-art R&D centers.
  • A distribution network comprises 8,500+ distributors, 70,000+ retailers, reaching over 75,00,000 farmers.
  • Strategic developments include the 2024 acquisition of KAEROS and a collaboration with Corteva Agriscience.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Gross Profit Margin (FY23)
23.1%
Gross Profit Margin (FY26)
31.5%
EBITDA Margin (FY23)
6.8%
EBITDA Margin (FY26)
10.6%
ROE (FY23)
6.9%
ROE (FY26)
11.4%
ROCE (FY23)
10.4%
ROCE (FY26)
16.1%
Formulations
130+
Technical Products
20+
Patents
27
Distributors
8,500+
Retailers
70,000+
Farmers Reach
75,00,000+
🏢 How This Affects the Company
📈
Business Impact
The company's acquisition of KAEROS in 2024 is intended to expand its independent dealer ecosystem and deepen distribution. Collaboration with Corteva Agriscience aims to broaden the crop solutions portfolio with differentiated offerings.
💰
Financial Impact
The presentation highlights profitability improvements from FY23 to FY26, with Gross Profit Margin improving from 23.1% to 31.5% and EBITDA Margin improving from 6.8% to 10.6%.
⚙️
Operational Impact
The company operates 6 formulation plants, 2 technical plants, and 4 R&D centers. Digitalization initiatives like "IIL 360" for team, "IIL Pariwar" for distributors, and "IIL Humsafar" for retailers are implemented to streamline operations.
👥 What This Means For Shareholders
✅
Action Required
No action required by shareholders based on this earnings presentation.
👤
Who Is Affected
Shareholders receive an update on the company's operational and strategic performance, including margin improvements and distribution network scale.
🔍
Management Signal
The presentation indicates management's focus on integrating solutions, expanding market access through acquisitions like KAEROS, and enhancing profitability.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — observe sustained margin improvements.
Updates on KAEROS integration — evaluate distribution network expansion impact.
Further details on Corteva Agriscience collaboration outcomes.
LOW RISK The filing is an earnings presentation, providing an overview of operations and strategy without immediately disclosing new risks.
💡 Investor Takeaway
Insecticides (India) filed its Q2 & H1 FY27 earnings presentation, showcasing a Gross Profit Margin improvement from 23.1% to 31.5% and an EBITDA Margin increase from 6.8% to 10.6% between FY23 and FY26. The company noted 130+ formulations, 20+ technical products, and 27 patents, supported by a distribution network of 8,500+ distributors.
⚖️ Strengths & Concerns

✅ Positives

  • Demonstrated profitability improvement with Gross Profit Margin increasing from 23.1% to 31.5% from FY23 to FY26.
  • Robust distribution network consisting of 8,500+ distributors and 70,000+ retailers, reaching over 75,00,000 farmers.
📅 Company Track Record
Previous filings from November 5, 2026, indicated Insecticides (India) Ltd reported Q2 FY27 revenue up 8% to Rs. 686.31 Crs, with PAT down 5%. Net profit was Rs. 5,057.59 In lacs, and an interim dividend of Rs. 5 was declared.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is Insecticides (India) Limited's Gross Profit Margin for FY26?
Insecticides (India) Limited's Gross Profit Margin improved to 31.5% in FY26, from 23.1% in FY23, according to the presentation.
How many formulations and technical products does Insecticides (India) Limited have?
Insecticides (India) Limited's product portfolio includes 130+ formulations and 20+ technical products.
What is the size of Insecticides (India) Limited's distribution network?
Insecticides (India) Limited has a distribution network comprising over 8,500 distributors and 70,000+ retailers, reaching more than 75,00,000 farmers.
What is Insecticides (India) Limited's EBITDA Margin for FY26?
The company's EBITDA Margin improved to 10.6% in FY26, up from 6.8% in FY23.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.